Medication abortion, a two-step process using mifepristone and misoprostol, constitutes over half of all US abortions and is increasingly vital due to abortion restrictions. Highly effective before ten weeks of pregnancy, mifepristone’s access has become fiercely contested since the overturning of Roe v. Wade. Recent legal challenges to the drug’s availability were dismissed by the Supreme Court due to the plaintiffs lacking legal standing. This ruling, however, does not guarantee continued nationwide access to the drug.
Read More
Texas Attorney General Ken Paxton’s announcement of the arrest of a woman for allegedly providing illegal abortions in Houston has sparked significant controversy and highlights the complex and highly charged nature of abortion access in the state. The arrest itself centers on allegations of providing abortions in violation of Texas’s strict abortion laws, which allow for exceptions only in cases of a life-threatening condition for the pregnant person or a risk of “substantial impairment of a major bodily function.”
This legal framework necessitates two in-person visits for an abortion – one for counseling and another 24 hours later for the procedure itself – a requirement viewed by many as an unnecessary obstacle, particularly in emergency situations.… Continue reading
Missouri clinics will “immediately” begin offering abortion services across the state following a recent judge’s ruling. This decision marks a significant shift in the state’s reproductive healthcare landscape, potentially ending the long-standing limitations imposed on abortion access. The swiftness with which clinics plan to resume services underscores the pent-up demand and the legal battles that have been waged to achieve this point.
The judge’s ruling is undoubtedly a victory for abortion rights advocates in Missouri. For years, restrictive laws have severely hampered the ability of clinics to provide abortions, forcing many women to travel out of state to access these services.… Continue reading
Dr. Margaret Carpenter, her company Nightingale Medical, and the mother of a minor are facing felony charges in Louisiana for allegedly procuring an abortion via mifepristone. The drug, mailed from New York to Louisiana, reportedly caused a medical emergency resulting in the termination of the minor’s pregnancy. This indictment marks a novel legal challenge following the overturning of Roe v. Wade, testing the limits of interstate abortion regulations. Prosecutors allege the actions constitute criminal abortion, highlighting the ongoing legal battles surrounding abortion access in the post-Roe era.
Read More
A national abortion ban has been introduced in the House of Representatives, a development many saw as inevitable despite prior assurances that the issue would remain at the state level. This swift action directly contradicts previous statements suggesting a hands-off approach, leaving many feeling betrayed and deeply concerned. The speed with which this bill materialized, and the considerable number of co-sponsors it already boasts, suggests a well-coordinated and determined effort to enact a nationwide prohibition.
This legislative move completely undermines the concept of states’ rights, a principle often championed by proponents of this very bill. The hypocrisy is glaring and fuels widespread anger and distrust.… Continue reading
The Department of Health and Human Services’ reproductiverights.gov website, providing information on reproductive healthcare access, including abortion, went offline around the time of President Trump’s inauguration. The site, active as recently as January 15th, detailed legal protections for reproductive healthcare, contrasting state-level abortion legality with federal protections like Affordable Care Act coverage of contraception. The website’s disappearance follows conflicting statements from Robert F. Kennedy Jr., Trump’s appointee to lead HHS, regarding abortion policy, and Trump’s own inconsistent stance on the issue. The site’s unavailability raises concerns given the ongoing debate surrounding abortion access in the United States.
Read More
Judge Matthew Kacsmaryk ruled that Idaho, Kansas, and Missouri can proceed with a lawsuit aiming to restrict access to mifepristone. The states seek to limit telehealth prescriptions, shorten the gestational limit for use, and mandate in-person visits, arguing these measures are necessary to uphold state abortion laws. The ACLU criticized the decision, viewing it as an attack on medication abortion. This case follows a previous ruling by Kacsmaryk against mifepristone and comes amidst ongoing efforts by multiple states to further restrict access to abortion pills. The outcome could significantly impact abortion access nationwide.
Read More
Mike Pence’s Advancing American Freedom group opposes Robert F. Kennedy Jr.’s nomination for HHS Secretary due to concerns over his past pro-choice statements, despite Kennedy’s recent assurances to pro-life senators. The organization worries Kennedy’s stance on abortion access, including late-term abortions, could undermine pro-life policies and funding. AAF’s skepticism highlights the division within the Republican party over Kennedy’s nomination, with some expressing confidence in his evolving views while others remain unconvinced. This opposition underscores the significant debate surrounding Kennedy’s fitness for the position, given his controversial past statements and lack of relevant expertise.
Read More
A recent study in JAMA Pediatrics reveals a concerning post-Dobbs decision increase in infant mortality rates, particularly among infants with congenital anomalies. This rise, showing a 7% overall increase and a 10% increase in anomaly-related deaths, is attributed to abortion bans preventing terminations of pregnancies with fatal fetal conditions. The study analyzed national CDC data from 2018-2023, highlighting spikes in infant deaths in specific months following the Supreme Court ruling. These findings directly contradict claims that abortion bans protect infant lives, instead demonstrating a tragic and foreseeable consequence of restricted reproductive healthcare access.
Read More
Former Vice President Mike Pence, through his organization Advancing American Freedom, urged Senate Republicans to reject Robert F. Kennedy Jr.’s nomination for Secretary of Health and Human Services, citing Kennedy’s pro-choice stance as a departure from the Trump-Pence administration’s pro-life record. This action demonstrates Pence’s willingness to publicly criticize his former running mate, despite congratulating Trump on his recent reelection. The upcoming Senate confirmation hearings will see Indiana Senators Todd Young and Jim Banks voting on the nomination, along with other controversial picks such as Matt Gaetz for Attorney General. Pence’s statement highlights a continuing rift between him and Trump stemming from the January 6th Capitol attack and differing political stances.
Read More
John Q. Hosedrinker 
Matt Underwood